Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",5.1635582782576856e-08,4.1576981940618305,69.76224589534839,"['CCR1', 'GPR65', 'GPR87', 'HTR1D', 'HTR2B', 'CXCR4', 'GPR4', 'ADRA1D', 'GPR3', 'SSTR1', 'GPR6', 'MCHR1', 'HCRTR2', 'HCRTR1', 'MC4R', 'OPN1SW', 'CYSLTR2', 'CNR2', 'GPR171', 'RHO', 'ACKR4', 'RGL4', 'OR7C1', 'GPR18']",1.74011913977284e-05,0,0,24
2,Spinal Cord Injury WP2431,7.575319632256735e-06,4.169855800140832,49.165164394105055,"['C1QB', 'NGFR', 'EGR1', 'BDNF', 'CXCL1', 'LILRB2', 'PDYN', 'CXCL2', 'AIF1', 'TNFSF13B', 'SELP', 'LGALS3', 'NR4A1', 'ZFP36', 'FCGR2A', 'CDK2']",0.0012764413580352598,0,0,16
3,Complement system WP2806,0.0001200820454418468,4.076040172166428,36.79578148037936,"['SELP', 'FCGR3A', 'CD93', 'CFH', 'CFI', 'ICAM2', 'F13A1', 'MASP2', 'PLG', 'VSIG4', 'SELE', 'TLR2']",0.013489216437967456,0,0,12
4,Selective expression of chemokine receptors during T-cell polarization WP4494,0.0002719183003760364,11.479194630872483,94.24429011932786,"['CCR1', 'IL4R', 'IL5', 'CXCR4', 'IL18R1']",0.021952934715890094,0,0,5
5,Complement and Coagulation Cascades WP558,0.0003257111975651349,4.711998527788001,37.83498966396574,"['C1QB', 'C1QA', 'SERPINA1', 'CFH', 'SERPIND1', 'CFI', 'MASP2', 'PLG', 'C1QC']",0.021952934715890094,0,0,9
6,Vitamin D Receptor Pathway WP2877,0.0006433286052692174,2.8424222147875544,20.888548461039974,"['LRRC25', 'COLEC11', 'IGFBP5', 'COL13A1', 'TNFRSF11B', 'SULT1C2', 'IL1RL1', 'CEACAM1', 'TRPV6', 'CASP5', 'DND1', 'CDK2', 'S100A4', 'S100A9', 'S100A8']",0.03613362332928771,0,0,15
7,Kynurenine Pathway and links to Cellular Senescence WP5044,0.0009155099257724061,8.19750719079578,57.350000919991864,"['IL1R2', 'HAAO', 'KYNU', 'KMO', 'ACMSD']",0.03880804871838908,0,0,5
8,Apoptosis Modulation and Signaling WP1772,0.0009212593167570108,3.3816689219666216,23.63708460356658,"['BCL2A1', 'BAG3', 'BIK', 'IL1R2', 'CASP4', 'CASP1', 'TNFRSF10C', 'TNFRSF11B', 'TNFRSF1B', 'TNFRSF10D', 'HSPA1A']",0.03880804871838908,0,0,11
9,Thyroxine (Thyroid Hormone) Production WP1981,0.0013401976393536206,22.906291834002676,151.52370450293265,"['TPO', 'TRH', 'CGA']",0.050182956051352236,0,0,3
10,Cytokines and Inflammatory Response WP530,0.0022018195305808508,9.171045576407506,56.1127782431154,"['IL5', 'IL7', 'CXCL1', 'CXCL2']",0.07420131818057468,0,0,4
11,NAD Biosynthesis II (from tryptophan) WP2485,0.003522553956821761,13.742168674698796,77.62358792119966,"['KYNU', 'HAAO', 'KMO']",0.10791824394990304,0,0,3
12,Peptide GPCRs WP24,0.004632603075264375,3.740242261103634,20.102442012802072,"['MC4R', 'CCR1', 'GNRHR', 'CXCR4', 'SSTR1', 'HCRTR2', 'HCRTR1']",0.12903319244917089,0,0,7
13,"COVID-19, thrombosis and anticoagulation WP4927",0.005133673826195391,45.75668449197861,241.22620837606618,"['F13A1', 'PLG']",0.12903319244917089,0,0,2
14,Microglia Pathogen Phagocytosis Pathway WP3937,0.005360429359906208,4.174242424242424,21.825908126202837,"['C1QB', 'C1QA', 'FCER1G', 'NCF4', 'SIGLEC7', 'C1QC']",0.12903319244917089,0,0,6
15,Complement Activation WP545,0.005888892696269176,6.549214860206817,33.62817034298578,"['C1QB', 'C1QA', 'MASP2', 'C1QC']",0.13230378924284747,0,0,4
16,Toll-like Receptor Signaling related to MyD88 WP3858,0.007663279127771018,4.587651006711409,22.347894550450622,"['IRF7', 'TLR9', 'TLR5', 'RELB', 'TLR2']",0.16140781662867706,0,0,5
17,Gastric acid production WP2596,0.009981752361810444,22.877005347593585,105.39428623697268,"['GRP', 'MUC6']",0.19787356152530117,0,0,2
18,Hematopoietic Stem Cell Differentiation WP2849,0.013307154992611911,3.358182533438238,14.50551302581603,"['TPO', 'IL5', 'RHOH', 'CXCR4', 'GATA1', 'RUNX1']",0.2491395129172341,0,0,6
19,Circadian rhythm related genes WP3594,0.01809535669446647,1.9659663308589608,7.887653338785203,"['NTRK1', 'EGR1', 'NGFR', 'TPH1', 'EGR3', 'HOMER1', 'CARTPT', 'HCRTR2', 'RELB', 'HCRTR1', 'PER2', 'SIX3', 'CRH', 'UTS2']",0.32095448452816844,0,0,14
20,Tryptophan catabolism leading to NAD+ production WP4210,0.02298846100926886,5.723560910307898,21.593638167829464,"['HAAO', 'KYNU', 'KMO']",0.3521414254601639,0,0,3
21,ID signaling pathway WP53,0.02298846100926886,5.723560910307898,21.593638167829464,"['CDK2', 'ELK1', 'PAX2']",0.3521414254601639,0,0,3
22,Platelet-mediated interactions with vascular and circulating cells WP4462,0.02298846100926886,5.723560910307898,21.593638167829464,"['SELP', 'SELE', 'TLR2']",0.3521414254601639,0,0,3
23,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.025082733468177902,3.984380463923534,14.684735336066767,"['BCL2A1', 'CXCL2', 'SELE', 'RELB']",0.3675165729902588,0,0,4
24,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.03229246378518241,4.905335628227195,16.83963162937111,"['TLR9', 'TLR5', 'TLR2']",0.45344001231693637,0,0,3
25,Sleep regulation WP3591,0.03550528656774151,3.524025572282945,11.763456997046445,"['CRH', 'UTS2', 'HCRTR2', 'HCRTR1']",0.4786112629331556,0,0,4
26,Selenium Micronutrient Network WP15,0.03772389319843492,2.361689494101813,7.740346659771313,"['SERPINA3', 'GPX3', 'KYNU', 'DIO3', 'PLG', 'KMO', 'XDH']",0.48895969261048344,0,0,7
27,Lung fibrosis WP3624,0.04272848119830754,2.7947290882304796,8.811472204748647,"['SERPINA1', 'CYSLTR2', 'IL5', 'HMOX1', 'CXCL2']",0.5333147468085052,0,0,5
28,Fatty Acid Omega Oxidation WP206,0.05209179968467349,6.534377387318564,19.307436806368166,"['CYP2A6', 'ADH1B']",0.6244229963305123,0,0,2
29,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.05373372965455447,2.6037217815741305,7.6125387671796485,"['CXCL17', 'IRF7', 'CXCL1', 'CXCL2', 'CXCL5']",0.6244229963305123,0,0,5
30,NRF2 pathway WP2884,0.06037925817779466,1.89484827099506,5.319046849120306,"['EGR1', 'DNAJB1', 'CYP2A6', 'SERPINA1', 'GPX3', 'HMOX1', 'SLC5A3', 'EPHA2', 'HSPA1A']",0.6278394217864149,0,0,9
31,Inflammatory Response Pathway WP453,0.06272214747874703,3.613400972310294,10.005654229066142,"['IL4R', 'IL5', 'TNFRSF1B']",0.6278394217864149,0,0,3
32,Cardiac Progenitor Differentiation WP2406,0.06281020516719255,2.8622654155495977,7.921713717414323,"['ACTC1', 'CXCR4', 'THY1', 'NODAL']",0.6278394217864149,0,0,4
33,Tryptophan metabolism WP465,0.06281020516719255,2.8622654155495977,7.921713717414323,"['TPH1', 'HAAO', 'KYNU', 'ACMSD']",0.6278394217864149,0,0,4
34,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.06334284967578073,5.717245989304812,15.774986535068397,"['SOCS3', 'CHI3L1']",0.6278394217864149,0,0,2
35,Oxidative Damage WP3941,0.07379644068510127,2.693581454029333,7.0206713142665365,"['C1QB', 'C1QA', 'TNFRSF1B', 'C1QC']",0.7050814971691903,0,0,4
36,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.07532027862934972,5.0816993464052285,13.141304369491214,"['HSD11B2', 'HSD3B1']",0.7050814971691903,0,0,2
37,Iron metabolism in placenta WP2007,0.08794344365446534,4.5732620320855615,11.117880600996665,"['HEPHL1', 'HAMP']",0.7901217807402691,0,0,2
38,TYROBP causal network in microglia WP3945,0.09033951359072617,2.2021166752710375,5.294285601608038,"['RGS1', 'HCLS1', 'TCIRG1', 'TNFRSF1B', 'C1QC']",0.7901217807402691,0,0,5
39,Pre-implantation embryo WP3527,0.09195817848574146,2.4747482066516917,5.9057920477029,"['EGR1', 'ZFP36', 'ARGFX', 'SIX3']",0.7901217807402691,0,0,4
40,7-oxo-C and 7beta-HC pathways WP5064,0.09378300068133756,2.9842849659507595,7.063121109050084,"['HSD11B2', 'THEM5', 'ACOT6']",0.7901217807402691,0,0,3
41,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.10237054018756592,2.859772423025435,6.517868338077227,"['CXCL1', 'CXCL2', 'GLI2']",0.8414359034929197,0,0,3
42,Oncostatin M Signaling Pathway WP2374,0.10669740316879449,2.08163514338011,4.658196649937809,"['SOCS3', 'EGR1', 'PRKCH', 'CDK2', 'OSMR']",0.8561196397115177,0,0,5
43,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.1204255620775819,2.639481000926784,5.587051354318966,"['IRF7', 'TLR9', 'TLR2']",0.8931267064433166,0,0,3
44,Oxidative Stress WP408,0.1204255620775819,2.639481000926784,5.587051354318966,"['GPX3', 'HMOX1', 'XDH']",0.8931267064433166,0,0,3
45,Nicotine Metabolism WP1600,0.12074384357008575,11.423230974632844,24.149669519647983,['CYP2A6'],0.8931267064433166,0,0,1
46,Development and heterogeneity of the ILC family WP3893,0.12896117423380837,3.5172768408062525,7.204240815693573,"['IL5', 'IL7']",0.8931267064433166,0,0,2
47,ERK Pathway in Huntington's Disease WP3853,0.12896117423380837,3.5172768408062525,7.204240815693573,"['BDNF', 'ELK1']",0.8931267064433166,0,0,2
48,Major receptors targeted by epinephrine and norepinephrine WP4589,0.12896117423380837,3.5172768408062525,7.204240815693573,"['ADCY10', 'ADRA1D']",0.8931267064433166,0,0,2
49,Monoamine GPCRs WP58,0.12986115316238134,2.5415737022162723,5.188087589556045,"['HTR1D', 'HTR2B', 'ADRA1D']",0.8931267064433166,0,0,3
50,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.15828882077370732,3.0479500891265596,5.618389831766275,"['TNC', 'CXCR4']",0.9869351163430106,0,0,2
51,Proximal tubule transport WP4917,0.16534549381910912,1.9470651987907135,3.5041684651607445,"['SLC22A6', 'SLC3A1', 'ATP6V0A4', 'SLC22A8']",0.9869351163430106,0,0,4
52,Amyotrophic lateral sclerosis (ALS) WP2447,0.16994658139737565,2.2131105065422982,3.9222318325411005,"['CASP1', 'NEFM', 'NEFH']",0.9869351163430106,0,0,3
53,Regulatory circuits of the STAT3 signaling pathway WP4538,0.17040533828929386,1.7603510583376356,3.115073817452481,"['SOCS3', 'DUSP2', 'PTPRC', 'IL21R', 'OSMR']",0.9869351163430106,0,0,5
54,15q13.3 copy number variation syndrome WP4942,0.17337828129999613,2.8572860962566846,5.006763779241567,"['TRPM1', 'SERPINH1']",0.9869351163430106,0,0,2
55,Genes controlling nephrogenesis WP4823,0.18047300217610432,2.1438253012048194,3.6706021231211046,"['FOXC1', 'CXCR4', 'PAX2']",0.9869351163430106,0,0,3
56,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.18868569249537856,2.6890531613715005,4.484460414079425,"['HTR2B', 'ELK1']",0.9869351163430106,0,0,2
57,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.18868569249537856,2.6890531613715005,4.484460414079425,"['EGR1', 'ELK1']",0.9869351163430106,0,0,2
58,GDNF/RET signaling axis WP4830,0.18868569249537856,2.6890531613715005,4.484460414079425,"['FOXC1', 'PAX2']",0.9869351163430106,0,0,2
59,MAPK Signaling Pathway WP382,0.19033133701872765,1.3421589839500287,2.2266267846932104,"['DUSP4', 'NTRK1', 'DUSP2', 'BDNF', 'IL1R2', 'HSPB1', 'ELK1', 'DUSP6', 'RELB', 'NR4A1', 'CACNG1', 'HSPA1B', 'HSPA1A']",0.9869351163430106,0,0,13
60,Steroid Biosynthesis WP496,0.1930369541838051,5.710947930574099,9.393787687289194,['HSD3B1'],0.9869351163430106,0,0,1
61,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.1930369541838051,5.710947930574099,9.393787687289194,['REN'],0.9869351163430106,0,0,1
62,Acute viral myocarditis WP4298,0.19925861365376674,1.6579126544110494,2.6744646697415133,"['CASP1', 'CXCR4', 'NOD2', 'TLR5', 'AIF1']",0.9869351163430106,0,0,5
63,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.20202089978486132,2.0174816914717693,3.2267281850800402,"['CASP5', 'CASP1', 'NOD2']",0.9869351163430106,0,0,3
64,Oxysterols derived from cholesterol WP4545,0.20202089978486132,2.0174816914717693,3.2267281850800402,"['CYP39A1', 'THEM5', 'ACOT6']",0.9869351163430106,0,0,3
65,Pathways Regulating Hippo Signaling WP4540,0.20256824841802915,1.560300586510264,2.4912982751822663,"['NTRK1', 'NGFR', 'PRKCH', 'CDH17', 'TEAD2', 'EPHA2']",0.9869351163430106,0,0,6
66,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.20416623684870228,2.5395127748068926,4.03483054189243,"['DUSP6', 'HIST1H3E']",0.9869351163430106,0,0,2
67,Globo Sphingolipid Metabolism WP1424,0.21977846671050583,2.4057134815648746,3.64498119979604,"['FUT2', 'A4GALT']",0.9869351163430106,0,0,2
68,IL1 and megakaryocytes in obesity WP2865,0.21977846671050583,2.4057134815648746,3.64498119979604,"['S100A9', 'TLR2']",0.9869351163430106,0,0,2
69,Matrix Metalloproteinases WP129,0.21977846671050583,2.4057134815648746,3.64498119979604,"['MMP19', 'MMP21']",0.9869351163430106,0,0,2
70,Effects of nitric oxide WP1995,0.22692583122039917,4.56849132176235,6.775675897634564,['XDH'],0.9869351163430106,0,0,1
71,Hfe effect on hepcidin production WP3924,0.22692583122039917,4.56849132176235,6.775675897634564,['HAMP'],0.9869351163430106,0,0,1
72,let-7 inhibition of ES cell reprogramming WP3299,0.22692583122039917,4.56849132176235,6.775675897634564,['EGR1'],0.9869351163430106,0,0,1
73,Vitamin A and carotenoid metabolism WP716,0.23535162423338246,1.8535764680342994,2.681522013639096,"['RBP2', 'NPC1L1', 'RPE65']",0.9869351163430106,0,0,3
74,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.23548410105949713,2.2852941176470587,3.3047909710622623,"['BCL2A1', 'BCL2L14']",0.9869351163430106,0,0,2
75,Development of ureteric collection system WP5053,0.2466721601313113,1.804692454026633,2.5260192045745242,"['FOXC1', 'PAX2', 'GLI2']",0.9869351163430106,0,0,3
76,Toll-like Receptor Signaling Pathway WP75,0.25322412327472543,1.5045920169551394,2.0665275243956414,"['IRF7', 'TLR9', 'LY96', 'TLR5', 'TLR2']",0.9869351163430106,0,0,5
77,Allograft Rejection WP2328,0.25326525964121294,1.6045341235125348,2.2035354047760314,"['C1QB', 'C1QA', 'IL5', 'C1QC']",0.9869351163430106,0,0,4
78,Myometrial relaxation and contraction pathways WP289,0.25887147006287153,1.3459648010147456,1.818968590186214,"['RGS4', 'PRKCH', 'ACTC1', 'IGFBP5', 'RGS1', 'CRH', 'RXFP2', 'YWHAH']",0.9869351163430106,0,0,8
79,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.2593933424917007,3.8068535825545173,5.137005045927733,['CASP1'],0.9869351163430106,0,0,1
80,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.2593933424917007,3.8068535825545173,5.137005045927733,['IL5'],0.9869351163430106,0,0,1
81,COVID-19 adverse outcome pathway WP4891,0.2593933424917007,3.8068535825545173,5.137005045927733,['IL7'],0.9869351163430106,0,0,1
82,Molybdenum cofactor (Moco) biosynthesis WP4507,0.2593933424917007,3.8068535825545173,5.137005045927733,['XDH'],0.9869351163430106,0,0,1
83,Nanomaterial-induced inflammasome activation WP3890,0.2593933424917007,3.8068535825545173,5.137005045927733,['CASP1'],0.9869351163430106,0,0,1
84,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.26256960144531416,1.5767772949986132,2.1085282252148994,"['PRKCH', 'NOD2', 'TLR2', 'RELB']",0.9869351163430106,0,0,4
85,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.2670371490891747,2.077297034516286,2.742795482032205,"['BDNF', 'CGA']",0.9869351163430106,0,0,2
86,EPO Receptor Signaling WP581,0.2828221554790732,1.986863520111602,2.5092834629371854,"['PTPRC', 'CISH']",0.9869351163430106,0,0,2
87,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.29049902605487476,3.262826625977494,4.033359628422303,['TLR2'],0.9869351163430106,0,0,1
88,Dual hijack model of Vif in HIV infection WP3300,0.29049902605487476,3.262826625977494,4.033359628422303,['RUNX1'],0.9869351163430106,0,0,1
89,"GPCRs, Other WP117",0.3003493005403266,1.4747037965925798,1.7737872149256877,"['GNRHR', 'ADRA1D', 'OR10A2', 'GPR18']",0.9869351163430106,0,0,4
90,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.3142718068314783,1.8277005347593582,2.1155579601982977,"['CYSLTR2', 'TRPA1']",0.9869351163430106,0,0,2
91,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.3142718068314783,1.8277005347593582,2.1155579601982977,"['RAB25', 'HSPB1']",0.9869351163430106,0,0,2
92,Nuclear Receptors Meta-Pathway WP2882,0.3174880551162696,1.1850508414104775,1.359626704517285,"['SRGN', 'EGR1', 'SERPINA1', 'GPX3', 'AMIGO2', 'SLC5A3', 'DNAJB1', 'CYP2A6', 'PDK4', 'HMOX1', 'EPHA2', 'HSPA1A', 'FKBP5']",0.9869351163430106,0,0,13
93,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3202999294175086,2.8548064085447264,3.250189795619509,['TBX6'],0.9869351163430106,0,0,1
94,Tgif disruption of Shh signaling WP3674,0.3202999294175086,2.8548064085447264,3.250189795619509,['NODAL'],0.9869351163430106,0,0,1
95,Estrogen Receptor Pathway WP2881,0.3202999294175086,2.8548064085447264,3.250189795619509,['PDK4'],0.9869351163430106,0,0,1
96,Macrophage markers WP4146,0.3202999294175086,2.8548064085447264,3.250189795619509,['CD163'],0.9869351163430106,0,0,1
97,Hippo-Merlin Signaling Dysregulation WP4541,0.3231364088581691,1.306374807987711,1.4757864421224431,"['NTRK1', 'NGFR', 'CDH17', 'TEAD2', 'CD44', 'EPHA2']",0.9869351163430106,0,0,6
98,Ovarian infertility WP34,0.32988835378676185,1.7573015220074044,1.9488491515755966,"['EGR1', 'GJA4']",0.9869351163430106,0,0,2
99,Cell migration and invasion through p75NTR WP4561,0.34540411382349334,1.6921172509407802,1.7987886659796226,"['NGFR', 'BDNF']",0.9869351163430106,0,0,2
100,miRNAs involvement in the immune response in sepsis WP4329,0.34540411382349334,1.6921172509407802,1.7987886659796226,"['IRF7', 'RELB']",0.9869351163430106,0,0,2
101,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.34885071355134384,2.537457350541463,2.672224763396237,['ELK1'],0.9869351163430106,0,0,1
102,Tamoxifen metabolism WP691,0.34885071355134384,2.537457350541463,2.672224763396237,['CYP2A6'],0.9869351163430106,0,0,1
103,Autosomal recessive Osteopetrosis pathways WP4788,0.34885071355134384,2.537457350541463,2.672224763396237,['TCIRG1'],0.9869351163430106,0,0,1
104,Valproic acid pathway WP3871,0.34885071355134384,2.537457350541463,2.672224763396237,['CYP2A6'],0.9869351163430106,0,0,1
105,Dopamine metabolism WP2436,0.34885071355134384,2.537457350541463,2.672224763396237,['TYR'],0.9869351163430106,0,0,1
106,Gene regulatory network modelling somitogenesis  WP2854,0.34885071355134384,2.537457350541463,2.672224763396237,['TBX6'],0.9869351163430106,0,0,1
107,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.34885071355134384,2.537457350541463,2.672224763396237,['HMOX1'],0.9869351163430106,0,0,1
108,IL-4 signaling pathway WP395,0.35071317383154244,1.4583440143552935,1.5280332554023437,"['SOCS3', 'IL4R', 'ELK1']",0.9869351163430106,0,0,3
109,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.35282896904920913,1.2308520550781654,1.2822670180677143,"['ADCYAP1', 'EGR1', 'TPH1', 'BDNF', 'SST', 'SSTR1', 'YWHAH']",0.9869351163430106,0,0,7
110,Regulation of toll-like receptor signaling pathway WP1449,0.3531099708668695,1.2581385025155372,1.309691656620486,"['CISH', 'IRF7', 'TLR9', 'LY96', 'TLR5', 'TLR2']",0.9869351163430106,0,0,6
111,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.36080003667668153,1.6315889992360582,1.6632930399965942,"['SERPINH1', 'TNFRSF11B']",0.9869351163430106,0,0,2
112,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3622986514569223,1.4278781793842035,1.4497053010411107,"['SOCS3', 'HSPB1', 'YBX3']",0.9869351163430106,0,0,3
113,Pathogenic Escherichia coli infection WP2272,0.3622986514569223,1.4278781793842035,1.4497053010411107,"['HCLS1', 'LY96', 'TLR5']",0.9869351163430106,0,0,3
114,IL-18 signaling pathway WP4754,0.3727772956014578,1.1483184112802072,1.133130867243033,"['SOCS3', 'NR4A1', 'SLC12A3', 'HMOX1', 'HSPB1', 'TNFRSF11B', 'GATA1', 'CXCL2', 'IL18R1', 'TGM2', 'MYH7']",0.9869351163430106,0,0,11
115,Folate Metabolism WP176,0.3738513306514379,1.3986558478813211,1.376133393778663,"['SERPINA3', 'GPX3', 'PLG']",0.9869351163430106,0,0,3
116,Phosphodiesterases in neuronal function WP4222,0.3738513306514379,1.3986558478813211,1.376133393778663,"['ADCY10', 'PDE10A', 'PDE6A']",0.9869351163430106,0,0,3
117,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.37605884521987226,1.5752351097178683,1.540595129805992,"['LY96', 'PLG']",0.9869351163430106,0,0,2
118,Prion disease pathway WP3995,0.37605884521987226,1.5752351097178683,1.540595129805992,"['ELK1', 'BATF']",0.9869351163430106,0,0,2
119,Biogenic Amine Synthesis WP550,0.3762037524800531,2.2835781041388516,2.2324816452997935,['TPH1'],0.9869351163430106,0,0,1
120,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.3762037524800531,2.2835781041388516,2.2324816452997935,['TPO'],0.9869351163430106,0,0,1
121,Osteoblast Signaling WP322,0.3762037524800531,2.2835781041388516,2.2324816452997935,['TNFRSF11B'],0.9869351163430106,0,0,1
122,Apoptosis WP254,0.396385705385171,1.2691391123026512,1.1744201360652693,"['CASP4', 'CASP1', 'IRF7', 'TNFRSF1B']",0.9869351163430106,0,0,4
123,Serotonin and anxiety-related events WP3944,0.40240922895373477,2.075858720718534,1.8896245620065701,['CRH'],0.9869351163430106,0,0,1
124,ACE Inhibitor Pathway WP554,0.40240922895373477,2.075858720718534,1.8896245620065701,['REN'],0.9869351163430106,0,0,1
125,Sulfation Biotransformation Reaction WP692,0.40240922895373477,2.075858720718534,1.8896245620065701,['SULT1C2'],0.9869351163430106,0,0,1
126,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.40240922895373477,2.075858720718534,1.8896245620065701,['SST'],0.9869351163430106,0,0,1
127,EDA signaling in hair follicle development WP3930,0.40240922895373477,2.075858720718534,1.8896245620065701,['RELB'],0.9869351163430106,0,0,1
128,LTF danger signal response pathway WP4478,0.40240922895373477,2.075858720718534,1.8896245620065701,['TLR2'],0.9869351163430106,0,0,1
129,Purine metabolism WP4792,0.40240922895373477,2.075858720718534,1.8896245620065701,['XDH'],0.9869351163430106,0,0,1
130,RalA downstream regulated genes WP2290,0.40240922895373477,2.075858720718534,1.8896245620065701,['YBX3'],0.9869351163430106,0,0,1
131,BDNF-TrkB Signaling WP3676,0.4061041919439798,1.4734345351043643,1.327778933122788,"['HOMER1', 'BDNF']",0.9869351163430106,0,0,2
132,Zinc homeostasis WP3529,0.4061041919439798,1.4734345351043643,1.327778933122788,"['MT1A', 'SLC30A2']",0.9869351163430106,0,0,2
133,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4061041919439798,1.4734345351043643,1.327778933122788,"['FYB1', 'TEAD2']",0.9869351163430106,0,0,2
134,Calcium Regulation in the Cardiac Cell WP536,0.40808402254758364,1.158952152456746,1.0387481711808337,"['RGS4', 'PRKCH', 'PLN', 'RGS1', 'GJA4', 'ADRA1D', 'YWHAH']",0.9869351163430106,0,0,7
135,Prader-Willi and Angelman Syndrome WP3998,0.40822508445176275,1.317732468334878,1.1806047198730063,"['BDNF', 'CGA', 'TYR']",0.9869351163430106,0,0,3
136,p38 MAPK Signaling Pathway WP400,0.42086403793784305,1.4273061497326203,1.2352556097971772,"['HSPB1', 'ELK1']",0.9869351163430106,0,0,2
137,Farnesoid X receptor pathway WP2879,0.4275152257524361,1.9027592345349356,1.6168989153148356,['FKBP5'],0.9869351163430106,0,0,1
138,Osteoclast Signaling WP12,0.4275152257524361,1.9027592345349356,1.6168989153148356,['TNFRSF11B'],0.9869351163430106,0,0,1
139,Endoderm differentiation WP2853,0.4285048411112941,1.1517348875033884,0.976041465719953,"['DUSP4', 'DUSP5', 'DUSP2', 'GRHL2', 'NODAL', 'GLI2']",0.9869351163430106,0,0,6
140,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.43543318653073265,1.383973424080376,1.1506547590327567,"['IFITM3', 'IFITM2']",0.9869351163430106,0,0,2
141,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.44980162609063673,1.3431896822900282,1.0731395488690936,"['HSD3B1', 'REN']",0.9869351163430106,0,0,2
142,Cells and molecules involved in local acute inflammatory response  WP4493,0.4515678136813353,1.7562904385334293,1.396303097322058,['SELP'],0.9869351163430106,0,0,1
143,Cysteine and methionine catabolism WP4504,0.4515678136813353,1.7562904385334293,1.396303097322058,['SQOR'],0.9869351163430106,0,0,1
144,Hedgehog Signaling Pathway Netpath WP47,0.4515678136813353,1.7562904385334293,1.396303097322058,['GLI2'],0.9869351163430106,0,0,1
145,Nephrogenesis WP5052,0.4515678136813353,1.7562904385334293,1.396303097322058,['PAX2'],0.9869351163430106,0,0,1
146,Phytochemical activity on NRF2 transcriptional activation WP3,0.4515678136813353,1.7562904385334293,1.396303097322058,['HMOX1'],0.9869351163430106,0,0,1
147,Corticotropin-releasing hormone signaling pathway WP2355,0.4532084322021113,1.1711005705643776,0.9268126735822908,"['NR4A1', 'HSD3B1', 'CRH', 'ELK1']",0.9869351163430106,0,0,4
148,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.46396051892685625,1.3047364400305577,1.001979941246886,"['NGFR', 'BDNF']",0.9869351163430106,0,0,2
149,Neovascularisation processes WP4331,0.46396051892685625,1.3047364400305577,1.001979941246886,"['CXCR4', 'RELB']",0.9869351163430106,0,0,2
150,Cori Cycle WP1946,0.4746111355494947,1.6307457562464238,1.2153287216501636,['PGAM1'],0.9869351163430106,0,0,1
151,Drug Induction of Bile Acid Pathway WP2289,0.4746111355494947,1.6307457562464238,1.2153287216501636,['SLC51A'],0.9869351163430106,0,0,1
152,Leptin Insulin Overlap WP3935,0.4746111355494947,1.6307457562464238,1.2153287216501636,['SOCS3'],0.9869351163430106,0,0,1
153,Overview of nanoparticle effects WP3287,0.4746111355494947,1.6307457562464238,1.2153287216501636,['HMOX1'],0.9869351163430106,0,0,1
154,3q29 copy number variation syndrome WP4906,0.4750126691382928,1.1809998615150257,0.8791525987643573,"['TM4SF19', 'SLC51A', 'HAMP']",0.9869351163430106,0,0,3
155,Differentiation Pathway WP2848,0.4779021211668921,1.2684194890077243,0.9365366860724907,"['TPO', 'NODAL']",0.9869351163430106,0,0,2
156,IL-2 signaling pathway WP49,0.4779021211668921,1.2684194890077243,0.9365366860724907,"['SOCS3', 'CISH']",0.9869351163430106,0,0,2
157,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4779021211668921,1.2684194890077243,0.9365366860724907,"['PRKCH', 'HSD3B1']",0.9869351163430106,0,0,2
158,Neural Crest Cell Migration during Development WP4564,0.4779021211668921,1.2684194890077243,0.9365366860724907,"['NGFR', 'BDNF']",0.9869351163430106,0,0,2
159,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4858148542161782,1.1609148458239738,0.8380965683672909,"['NEFM', 'ELK1', 'NEFH']",0.9869351163430106,0,0,3
160,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4901089284706442,1.113712155888315,0.794218887490828,"['MC4R', 'TPO', 'DIO3', 'TRH']",0.9869351163430106,0,0,4
161,Serotonin and anxiety WP3947,0.49668748675795477,1.521940364931019,1.0650451161340517,['CRH'],0.9869351163430106,0,0,1
162,Small Ligand GPCRs WP247,0.49668748675795477,1.521940364931019,1.0650451161340517,['CNR2'],0.9869351163430106,0,0,1
163,Dopaminergic Neurogenesis WP2855,0.49668748675795477,1.521940364931019,1.0650451161340517,['GLI2'],0.9869351163430106,0,0,1
164,Glutathione metabolism WP100,0.49668748675795477,1.521940364931019,1.0650451161340517,['GPX3'],0.9869351163430106,0,0,1
165,Hypertrophy Model WP516,0.49668748675795477,1.521940364931019,1.0650451161340517,['NR4A3'],0.9869351163430106,0,0,1
166,MAPK pathway in congenital thyroid cancer WP4928,0.49668748675795477,1.521940364931019,1.0650451161340517,['ELK1'],0.9869351163430106,0,0,1
167,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.49668748675795477,1.521940364931019,1.0650451161340517,['SFRP4'],0.9869351163430106,0,0,1
168,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5175537192526887,1.104547221142635,0.7275011399201374,"['EGR1', 'CDK2', 'CGA']",0.9869351163430106,0,0,3
169,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.517837392451453,1.4267356475300401,0.9389261694972991,['TNC'],0.9869351163430106,0,0,1
170,Blood Clotting Cascade WP272,0.517837392451453,1.4267356475300401,0.9389261694972991,['PLG'],0.9869351163430106,0,0,1
171,Cancer immunotherapy by PD-1 blockade WP4585,0.517837392451453,1.4267356475300401,0.9389261694972991,['BATF'],0.9869351163430106,0,0,1
172,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.517837392451453,1.4267356475300401,0.9389261694972991,['HSPB1'],0.9869351163430106,0,0,1
173,miR-509-3p alteration of YAP1/ECM axis WP3967,0.517837392451453,1.4267356475300401,0.9389261694972991,['TEAD2'],0.9869351163430106,0,0,1
174,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5183605803938067,1.1706430824077882,0.7692110472336765,"['CISH', 'RELB']",0.9869351163430106,0,0,2
175,Vitamin B12 metabolism WP1533,0.5183605803938067,1.1706430824077882,0.7692110472336765,"['SERPINA3', 'PLG']",0.9869351163430106,0,0,2
176,Glycolysis and Gluconeogenesis WP534,0.5183605803938067,1.1706430824077882,0.7692110472336765,"['LDHC', 'PGAM1']",0.9869351163430106,0,0,2
177,Neural Crest Cell Migration in Cancer WP4565,0.5183605803938067,1.1706430824077882,0.7692110472336765,"['NGFR', 'BDNF']",0.9869351163430106,0,0,2
178,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5278967813804465,1.0869509785172435,0.6944035284662727,"['CASP1', 'HSPA1B', 'HSPA1A']",0.9963713885251022,0,0,3
179,Oxidation by Cytochrome P450 WP43,0.5313748803429611,1.1413101604278075,0.7216361680195914,"['CYP39A1', 'CYP2A6']",0.9963713885251022,0,0,2
180,Apoptosis Modulation by HSP70 WP384,0.5380996816367021,1.3427314851174115,0.8321060811486605,['HSPA1A'],0.9963713885251022,0,0,1
181,BMP Signaling Pathway in Eyelid Development WP3927,0.5380996816367021,1.3427314851174115,0.8321060811486605,['FOXC1'],0.9963713885251022,0,0,1
182,Transcription co-factors SKI and SKIL protein partners WP4533,0.5380996816367021,1.3427314851174115,0.8321060811486605,['TEAD2'],0.9963713885251022,0,0,1
183,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5441470616682897,1.1134081126907527,0.6775486238891995,"['ACTC1', 'TEAD2']",0.999885714423265,0,0,2
184,MECP2 and Associated Rett Syndrome WP3584,0.5482063091951742,1.0533827618164968,0.6331921558219713,"['BDNF', 'SST', 'FKBP5']",0.999885714423265,0,0,3
185,Ebola Virus Pathway on Host WP4217,0.5555914791393189,1.0097404525746867,0.593446682854211,"['SOCS3', 'SCIN', 'ICAM2', 'IRF7', 'RELB']",0.999885714423265,0,0,5
186,Regulation of Microtubule Cytoskeleton WP2038,0.556674492067409,1.0868347338935573,0.6366401866556474,"['RHO', 'PHLDB2']",0.999885714423265,0,0,2
187,Senescence and Autophagy in Cancer WP615,0.5689384524900788,1.0030344990130513,0.565694424475324,"['IGFBP5', 'IRF7', 'CXCL1', 'CD44']",0.999885714423265,0,0,4
188,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5761086678361752,1.2012507905277212,0.6624405316352856,['FCGR2A'],0.999885714423265,0,0,1
189,Imatinib and Chronic Myeloid Leukemia WP3640,0.5761086678361752,1.2012507905277212,0.6624405316352856,['SPRED2'],0.999885714423265,0,0,1
190,Exercise-induced Circadian Regulation WP410,0.5927713622079381,1.0142008318478906,0.530372791065546,"['PER2', 'CLDN5']",0.999885714423265,0,0,2
191,Differentiation of white and brown adipocyte WP2895,0.5939251651702123,1.1411214953271027,0.5945265266693981,['PLAC8'],0.999885714423265,0,0,1
192,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5939251651702123,1.1411214953271027,0.5945265266693981,['IL4R'],0.999885714423265,0,0,1
193,Purine metabolism and related disorders WP4224,0.5939251651702123,1.1411214953271027,0.5945265266693981,['XDH'],0.999885714423265,0,0,1
194,Hippo-Yap signaling pathway WP4537,0.6109937742583664,1.0867187996694005,0.5353921310530374,['TEAD2'],0.999885714423265,0,0,1
195,NAD+ biosynthetic pathways WP3645,0.6109937742583664,1.0867187996694005,0.5353921310530374,['ACMSD'],0.999885714423265,0,0,1
196,NRF2-ARE regulation WP4357,0.6109937742583664,1.0867187996694005,0.5353921310530374,['HMOX1'],0.999885714423265,0,0,1
197,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6109937742583664,1.0867187996694005,0.5353921310530374,['HMOX1'],0.999885714423265,0,0,1
198,Leptin signaling pathway WP2034,0.6150556115344598,0.9505800981704596,0.46202241292145674,"['SOCS3', 'CISH', 'ELK1']",0.999885714423265,0,0,3
199,Prolactin Signaling Pathway WP2037,0.6150556115344598,0.9505800981704596,0.46202241292145674,"['SOCS3', 'CISH', 'ELK1']",0.999885714423265,0,0,3
200,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6155908312938918,0.9709295710547275,0.4710685904955131,"['IRF7', 'ELK1']",0.999885714423265,0,0,2
201,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6155908312938918,0.9709295710547275,0.4710685904955131,"['HOMER1', 'BDNF']",0.999885714423265,0,0,2
202,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6155908312938918,0.9709295710547275,0.4710685904955131,"['IL5', 'PTPRC']",0.999885714423265,0,0,2
203,22q11.2 copy number variation syndrome WP4657,0.6175383762803691,0.9406594621486416,0.45341109074403124,"['CLDN5', 'FOXC1', 'ACTC1', 'SERPIND1']",0.999885714423265,0,0,4
204,Constitutive Androstane Receptor Pathway WP2875,0.6273458492298548,1.0372618036169439,0.48363088457963443,['CYP2A6'],0.999885714423265,0,0,1
205,Estrogen signaling pathway WP712,0.6273458492298548,1.0372618036169439,0.48363088457963443,['ELK1'],0.999885714423265,0,0,1
206,IL-7 signaling pathway WP205,0.6273458492298548,1.0372618036169439,0.48363088457963443,['IL7'],0.999885714423265,0,0,1
207,RAS and bradykinin pathways in COVID-19 WP4969,0.6273458492298548,1.0372618036169439,0.48363088457963443,['REN'],0.999885714423265,0,0,1
208,Mesodermal commitment pathway WP2857,0.6416513671105135,0.9121610738255034,0.40473514027884144,"['FOXC1', 'TBX6', 'GRHL2', 'NODAL', 'TEAD2']",0.999885714423265,0,0,5
209,Metapathway biotransformation Phase I and II WP702,0.6416513671105135,0.9121610738255034,0.40473514027884144,"['CYP39A1', 'SULT1C2', 'CYP2A6', 'GPX3', 'GLYAT']",0.999885714423265,0,0,5
210,TLR4 Signaling and Tolerance WP3851,0.6430114313327889,0.9921054159168746,0.4381065854732227,['IRF7'],0.999885714423265,0,0,1
211,Pregnane X receptor pathway WP2876,0.6430114313327889,0.9921054159168746,0.4381065854732227,['CYP2A6'],0.999885714423265,0,0,1
212,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6430114313327889,0.9921054159168746,0.4381065854732227,['PLA1A'],0.999885714423265,0,0,1
213,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6580193040648395,0.9507120605251447,0.39789297236306076,['HIST1H3E'],0.999885714423265,0,0,1
214,Interferon type I signaling pathways WP585,0.6582567999219502,0.8945685225962042,0.3740729079126405,"['SOCS3', 'PTPRC']",0.999885714423265,0,0,2
215,RANKL/RANK signaling pathway WP2018,0.6582567999219502,0.8945685225962042,0.3740729079126405,"['TNFRSF11B', 'RELB']",0.999885714423265,0,0,2
216,Amino Acid metabolism WP3925,0.6585342159093938,0.8885933343764669,0.3711999120974231,"['TPH1', 'TPO', 'PDK4']",0.999885714423265,0,0,3
217,Gastrin signaling pathway WP4659,0.669709947744732,0.8769849453495566,0.35159253795678475,"['EGR1', 'PRKCH', 'ELK1', 'CD44']",0.999885714423265,0,0,4
218,Cannabinoid receptor signaling WP3869,0.6723970455605983,0.912630173564753,0.362228639292047,['CNR2'],0.999885714423265,0,0,1
219,Purinergic signaling WP4900,0.6723970455605983,0.912630173564753,0.362228639292047,['GNAT3'],0.999885714423265,0,0,1
220,Hepatitis B infection WP4666,0.6742791537377275,0.8768198244708312,0.3455644072260338,"['EGR3', 'ATP6AP1', 'IRF7', 'ELK1', 'TLR2']",0.999885714423265,0,0,5
221,Cytosolic DNA-sensing pathway WP4655,0.6781265311964735,0.8607103218645948,0.3343182946743632,"['CASP1', 'IRF7']",0.999885714423265,0,0,2
222,Striated Muscle Contraction Pathway WP383,0.686171079049523,0.8774776625243915,0.3304829167955801,['ACTC1'],0.999885714423265,0,0,1
223,Gastric Cancer Network 2 WP2363,0.686171079049523,0.8774776625243915,0.3304829167955801,['PLAC8'],0.999885714423265,0,0,1
224,Monoamine Transport WP727,0.686171079049523,0.8774776625243915,0.3304829167955801,['TNFRSF11B'],0.999885714423265,0,0,1
225,16p11.2 distal deletion syndrome WP4950,0.6993667212273719,0.8449290411907234,0.302129758126635,['PLN'],0.999885714423265,0,0,1
226,Ethanol effects on histone modifications WP3996,0.6993667212273719,0.8449290411907234,0.302129758126635,['ADH1B'],0.999885714423265,0,0,1
227,IL17 signaling pathway WP2112,0.6993667212273719,0.8449290411907234,0.302129758126635,['IL17RB'],0.999885714423265,0,0,1
228,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7061525078303391,0.8144576012223071,0.28336938559074737,"['SCIN', 'SERPINH1']",0.999885714423265,0,0,2
229,Endochondral Ossification WP474,0.7061525078303391,0.8144576012223071,0.28336938559074737,"['SCIN', 'SERPINH1']",0.999885714423265,0,0,2
230,PDGFR-beta pathway WP3972,0.7120082285449632,0.8147053213808888,0.27672754346173806,['ELK1'],0.999885714423265,0,0,1
231,SARS-CoV-2 mitochondrial interactions WP5038,0.7120082285449632,0.8147053213808888,0.27672754346173806,['IRF7'],0.999885714423265,0,0,1
232,Type II interferon signaling (IFNG) WP619,0.7241188412157734,0.786565996040698,0.2539033106096552,['SOCS3'],0.999885714423265,0,0,1
233,Endothelin Pathways WP2197,0.7241188412157734,0.786565996040698,0.2539033106096552,['ADCY10'],0.999885714423265,0,0,1
234,GABA receptor Signaling WP4159,0.7241188412157734,0.786565996040698,0.2539033106096552,['SLC32A1'],0.999885714423265,0,0,1
235,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7278739688573076,0.8196127661629086,0.26033144362509775,"['NTRK1', 'NGFR', 'EGR1', 'BDNF', 'ELK1']",0.999885714423265,0,0,5
236,Tumor suppressor activity of SMARCB1 WP4204,0.7357208263496962,0.7603026257231865,0.23334033082834946,['GLI2'],0.999885714423265,0,0,1
237,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7357208263496962,0.7603026257231865,0.23334033082834946,['GLI2'],0.999885714423265,0,0,1
238,Heart Development WP1591,0.7357208263496962,0.7603026257231865,0.23334033082834946,['FOXC1'],0.999885714423265,0,0,1
239,p53 transcriptional gene network WP4963,0.7403234416887223,0.7599821746880571,0.22850240023179647,"['RPRM', 'TNFRSF10D']",0.999885714423265,0,0,2
240,B Cell Receptor Signaling Pathway WP23,0.7413674219585338,0.77701715954728,0.2325293241301193,"['PTPRC', 'HCLS1', 'ELK1']",0.999885714423265,0,0,3
241,Fluoropyrimidine Activity WP1601,0.746835518220592,0.7357336663939016,0.21476824108433132,['CYP2A6'],0.999885714423265,0,0,1
242,Glucocorticoid Receptor Pathway WP2880,0.7483173564956883,0.747479617778557,0.21671535852406967,"['SRGN', 'AMIGO2']",0.999885714423265,0,0,2
243,Disruption of postsynaptic signaling by CNV WP4875,0.7574833572625336,0.712700267022697,0.19795514503000744,['HOMER1'],0.999885714423265,0,0,1
244,MAPK Cascade WP422,0.7574833572625336,0.712700267022697,0.19795514503000744,['ELK1'],0.999885714423265,0,0,1
245,Melatonin metabolism and effects WP3298,0.7574833572625336,0.712700267022697,0.19795514503000744,['PER2'],0.999885714423265,0,0,1
246,Signaling of Hepatocyte Growth Factor Receptor WP313,0.767683927692899,0.6910628312497471,0.18270124462160137,['ELK1'],0.999885714423265,0,0,1
247,CAMKK2  Pathway WP4874,0.767683927692899,0.6910628312497471,0.18270124462160137,['HMOX1'],0.999885714423265,0,0,1
248,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7774559932275994,0.6706981858163826,0.16883367179481823,['BCL2A1'],0.999885714423265,0,0,1
249,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7868175314244631,0.6514972344077818,0.15620226729975123,['IGFBP5'],0.999885714423265,0,0,1
250,Nuclear receptors WP170,0.7868175314244631,0.6514972344077818,0.15620226729975123,['NR4A1'],0.999885714423265,0,0,1
251,PI3K-Akt signaling pathway WP4172,0.7874124214397477,0.8065938278704237,0.19277844573848316,"['NTRK1', 'NGFR', 'IL4R', 'BDNF', 'IL7', 'CDK2', 'TNC', 'OSMR', 'EPHA2', 'TLR2']",0.999885714423265,0,0,10
252,16p11.2 proximal deletion syndrome WP4949,0.7919526735755277,0.6803017000558704,0.15868285092451917,"['SPN', 'TBX6']",0.999885714423265,0,0,2
253,Vitamin D-sensitive calcium signaling in depression WP4698,0.7957857665136728,0.633363002521881,0.14467611290033297,['TPH1'],0.999885714423265,0,0,1
254,Ferroptosis WP4313,0.8043772011039684,0.6162089993865695,0.13414066640169103,['HMOX1'],0.999885714423265,0,0,1
255,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8126076461852701,0.5999578385215375,0.12449538276768535,['RELB'],0.999885714423265,0,0,1
256,Hedgehog Signaling Pathway WP4249,0.8126076461852701,0.5999578385215375,0.12449538276768535,['GLI2'],0.999885714423265,0,0,1
257,IL-5 signaling pathway WP127,0.8126076461852701,0.5999578385215375,0.12449538276768535,['ELK1'],0.999885714423265,0,0,1
258,PDGF Pathway WP2526,0.8126076461852701,0.5999578385215375,0.12449538276768535,['ELK1'],0.999885714423265,0,0,1
259,Chemokine signaling pathway WP3929,0.8191879803656851,0.700515570220664,0.13971201424663288,"['CCR1', 'FGR', 'CXCR4', 'CXCL5']",0.999885714423265,0,0,4
260,ATM Signaling Pathway WP2516,0.8204922501312594,0.5845400705213789,0.11565172864944051,['CDK2'],0.999885714423265,0,0,1
261,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8204922501312594,0.5845400705213789,0.11565172864944051,['HSPB1'],0.999885714423265,0,0,1
262,Nephrotic syndrome WP4758,0.8204922501312594,0.5845400705213789,0.11565172864944051,['PAX2'],0.999885714423265,0,0,1
263,Splicing factor NOVA regulated synaptic proteins WP4148,0.8280455264869282,0.5698931909212283,0.10753151768442004,['NCDN'],0.999885714423265,0,0,1
264,Aryl Hydrocarbon Receptor Netpath WP2586,0.8280455264869282,0.5698931909212283,0.10753151768442004,['CDK2'],0.999885714423265,0,0,1
265,DNA Replication WP466,0.8280455264869282,0.5698931909212283,0.10753151768442004,['CDK2'],0.999885714423265,0,0,1
266,IL-6 signaling pathway WP364,0.8280455264869282,0.5698931909212283,0.10753151768442004,['SOCS3'],0.999885714423265,0,0,1
267,Joubert Syndrome WP4656,0.8287717398606764,0.6241667277122556,0.11722506878318092,"['PDE6A', 'ARR3']",0.999885714423265,0,0,2
268,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8352813804547148,0.5559607932527924,0.10006550865382702,['CD44'],0.999885714423265,0,0,1
269,Metabolic reprogramming in colon cancer WP4290,0.8352813804547148,0.5559607932527924,0.10006550865382702,['PGAM1'],0.999885714423265,0,0,1
270,Integrated Cancer Pathway WP1971,0.8422131345378102,0.5426918430923772,0.09319221977943247,['CDK2'],0.999885714423265,0,0,1
271,Interleukin-11 Signaling Pathway WP2332,0.8422131345378102,0.5426918430923772,0.09319221977943247,['SOCS3'],0.999885714423265,0,0,1
272,Ras signaling WP4223,0.8461767255977445,0.6894041081960545,0.11514913147573276,"['NTRK1', 'NGFR', 'ELK1', 'PLA1A', 'EPHA2']",0.999885714423265,0,0,5
273,ATM Signaling Network in Development and Disease  WP3878,0.8488535525915346,0.5300400534045394,0.08685692231821172,['HSPB1'],0.999885714423265,0,0,1
274,Prostaglandin Synthesis and Regulation WP98,0.8488535525915346,0.5300400534045394,0.08685692231821172,['HSD11B2'],0.999885714423265,0,0,1
275,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8552148636560746,0.5179633450661488,0.08101078232640334,['ADCY10'],0.999885714423265,0,0,1
276,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8552148636560746,0.5179633450661488,0.08101078232640334,['ELK1'],0.999885714423265,0,0,1
277,Histone Modifications WP2369,0.8613087839137111,0.5064233793205756,0.07561012709589324,['HIST1H3E'],0.999885714423265,0,0,1
278,One-carbon metabolism and related pathways WP3940,0.8613087839137111,0.5064233793205756,0.07561012709589324,['GPX3'],0.999885714423265,0,0,1
279,Glioblastoma signaling pathways WP2261,0.864234894510954,0.5693181818181818,0.0830696021805052,"['PRKCH', 'CDK2']",0.999885714423265,0,0,2
280,Netrin-UNC5B signaling pathway WP4747,0.8671465384951561,0.49538515121611426,0.07061581507803427,['SELE'],0.999885714423265,0,0,1
281,Neural Crest Differentiation WP2064,0.8772648478074248,0.5486437729527737,0.07184289362691074,"['MIA', 'TBX6']",0.999885714423265,0,0,2
282,Synaptic Vesicle Pathway WP2267,0.8780961174131748,0.47468847352024923,0.061709130447623245,['SLC32A1'],0.999885714423265,0,0,1
283,Copper homeostasis WP3286,0.8832281168231307,0.46497370643851665,0.05773660757159922,['MT1A'],0.999885714423265,0,0,1
284,Translation Factors WP107,0.8881443375403715,0.45564753004005343,0.05404936881548313,['EEF1A2'],0.999885714423265,0,0,1
285,Oxidative phosphorylation WP623,0.8881443375403715,0.45564753004005343,0.05404936881548313,['ATP6AP1'],0.999885714423265,0,0,1
286,TNF-alpha signaling pathway WP231,0.8891325551600611,0.5294117647058824,0.06221061988231009,"['TNFRSF1B', 'SELE']",0.999885714423265,0,0,2
287,VEGFA-VEGFR2 Signaling Pathway WP3888,0.892856447131134,0.7332941803870742,0.08310383679921964,"['DUSP5', 'EGR1', 'EGR3', 'TNFRSF10C', 'HSPB1', 'ELK1', 'SELE', 'APOLD1', 'NR4A1', 'NR4A3', 'CLIC1', 'HSPA1A', 'EPHA2']",0.999885714423265,0,0,13
288,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8973653067643047,0.43807127451987266,0.04743972218679297,['TNFRSF11B'],0.999885714423265,0,0,1
289,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8973653067643047,0.43807127451987266,0.04743972218679297,['IRF7'],0.999885714423265,0,0,1
290,Modulators of TCR signaling and T cell activation WP5072,0.9016870530871756,0.4297805879537496,0.04447703331150047,['RHOH'],0.999885714423265,0,0,1
291,Insulin Signaling WP481,0.9029350486345539,0.5905086870234323,0.060293686692813396,"['SOCS3', 'EGR1', 'PRKCH', 'ELK1']",0.999885714423265,0,0,4
292,Small cell lung cancer WP4658,0.9065722918094076,0.5001762942939414,0.049059543585340135,"['CDK2', 'CKS2']",0.999885714423265,0,0,2
293,Wnt signaling pathway and pluripotency WP399,0.9157688135332649,0.48412788713164184,0.04259905819672645,"['PRKCH', 'CD44']",0.999885714423265,0,0,2
294,G1 to S cell cycle control WP45,0.930320492094369,0.37324082383068136,0.026957742893068654,['CDK2'],0.999885714423265,0,0,1
295,AGE/RAGE pathway WP2324,0.9332560117638987,0.3671992764546277,0.025364554205351043,['LGALS3'],0.999885714423265,0,0,1
296,Endometrial cancer WP4155,0.9332560117638987,0.3671992764546277,0.025364554205351043,['ELK1'],0.999885714423265,0,0,1
297,Pathways affected in adenoid cystic carcinoma WP3651,0.9332560117638987,0.3671992764546277,0.025364554205351043,['INSRR'],0.999885714423265,0,0,1
298,Melanoma WP4685,0.9387616922919327,0.35568257676902537,0.022476869885133387,['ELK1'],0.999885714423265,0,0,1
299,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9413420162438428,0.3501899969189689,0.021168545833913748,['PAX2'],0.999885714423265,0,0,1
300,Ciliopathies WP4803,0.9427519981615178,0.525066249283268,0.030953717784288994,"['DNAH11', 'RSPH4A', 'CCDC65', 'GLI2']",0.999885714423265,0,0,4
301,DNA damage response WP707,0.9438137506983171,0.34486385888255044,0.019942245895734987,['CDK2'],0.999885714423265,0,0,1
302,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9443937073600696,0.4834372952804124,0.027658480720997754,"['CLDN5', 'CLDN20', 'CLDN9']",0.999885714423265,0,0,3
303,Osteoblast differentiation WP4787,0.9446995376084542,0.42901826253657555,0.02440614179022049,"['PRKCH', 'GLI2']",0.999885714423265,0,0,2
304,miRNA regulation of DNA damage response WP1530,0.9484495158761227,0.3346815361658682,0.017713594697571843,['CDK2'],0.999885714423265,0,0,1
305,Male infertility WP4673,0.9484911210199362,0.4210239651416122,0.02226494750079262,"['DND1', 'ETV5']",0.999885714423265,0,0,2
306,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9506221077005367,0.3298117296491941,0.016701223546108885,['CACNG1'],0.999885714423265,0,0,1
307,Adipogenesis WP236,0.9520340763224839,0.4133203694701021,0.020316535590089554,"['SFRP4', 'SOCS3']",0.999885714423265,0,0,2
308,Cell cycle WP179,0.9613190005397668,0.3918034298358842,0.015456245135657335,"['CDK2', 'YWHAH']",0.999885714423265,0,0,2
309,Fragile X Syndrome  WP4549,0.9613190005397668,0.3918034298358842,0.015456245135657335,"['HOMER1', 'BDNF']",0.999885714423265,0,0,2
310,T-cell receptor (TCR) signaling pathway WP69,0.9634739834908617,0.29931136251844564,0.011137314014720253,['FYB1'],0.999885714423265,0,0,1
311,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9634739834908617,0.29931136251844564,0.011137314014720253,['SFRP4'],0.999885714423265,0,0,1
312,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9650140317049415,0.2954068628300938,0.010520217409311434,['CISH'],0.999885714423265,0,0,1
313,DNA IR-damage and cellular response via ATR WP4016,0.966489225249012,0.29160247851836635,0.009939307983912937,['CDK2'],0.999885714423265,0,0,1
314,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9729839294170428,0.2739556356266186,0.007503018449781149,['SFRP4'],0.999885714423265,0,0,1
315,Pathways in clear cell renal cell carcinoma WP4018,0.9729839294170428,0.2739556356266186,0.007503018449781149,['LDHC'],0.999885714423265,0,0,1
316,Retinoblastoma gene in cancer WP2446,0.9729839294170428,0.2739556356266186,0.007503018449781149,['CDK2'],0.999885714423265,0,0,1
317,Ectoderm Differentiation WP2858,0.974052191398861,0.3576361109941471,0.009402393614616455,"['STC1', 'TNFRSF11B']",0.999885714423265,0,0,2
318,Androgen receptor signaling pathway WP138,0.974123429412844,0.2706783648038655,0.007096444829668446,['ETV5'],0.999885714423265,0,0,1
319,Pancreatic adenocarcinoma pathway WP4263,0.975214923733499,0.26747820623576535,0.006713006912087899,['DUSP6'],0.999885714423265,0,0,1
320,ErbB signaling pathway WP673,0.9782211492665263,0.2583141157907513,0.005687950388851556,['ELK1'],0.999885714423265,0,0,1
321,G Protein Signaling Pathways WP35,0.9791399875279059,0.25539670872024123,0.005383930249208196,['PRKCH'],0.999885714423265,0,0,1
322,Integrin-mediated Cell Adhesion WP185,0.9838945847558263,0.2391820673178273,0.0038834836977534506,['RHO'],0.999885714423265,0,0,1
323,7q11.23 copy number variation syndrome WP4932,0.9852253639943458,0.23422295018787936,0.003486377707008556,['CLDN5'],0.999885714423265,0,0,1
324,Focal Adhesion WP306,0.9867960470585622,0.3675024422012374,0.004884805767795015,"['FGR', 'TNC', 'ELK1']",0.999885714423265,0,0,3
325,Integrated breast cancer pathway WP1984,0.9876154501353878,0.3086143548328422,0.0038459142880550774,"['CDK2', 'RHO']",0.999885714423265,0,0,2
326,Thermogenesis WP4321,0.9880913417270447,0.2226759862823634,0.00266768823594003,['ADCY10'],0.999885714423265,0,0,1
327,Wnt signaling WP428,0.9895369160162221,0.21627566914616314,0.0022748322328900866,['SFRP4'],0.999885714423265,0,0,1
328,DNA damage response (only ATM dependent) WP710,0.9895369160162221,0.21627566914616314,0.0022748322328900866,['BIK'],0.999885714423265,0,0,1
329,ESC Pluripotency Pathways WP3931,0.9895369160162221,0.21627566914616314,0.0022748322328900866,['ELK1'],0.999885714423265,0,0,1
330,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9913370261272011,0.41712276183164515,0.003629266503968586,"['NGFR', 'IL4R', 'TNC', 'OSMR', 'EPHA2']",0.999885714423265,0,0,5
331,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9953917064818993,0.18293208148499074,0.0008449531201200886,['TRIP10'],0.999885714423265,0,0,1
332,TGF-beta Signaling Pathway WP366,0.9961226303574534,0.17717373164218958,0.0006883033157217153,['TNC'],0.999885714423265,0,0,1
333,Nonalcoholic fatty liver disease WP4396,0.9974823121342861,0.16423830808227394,0.00041402220365769704,['SOCS3'],0.999885714423265,0,0,1
334,Regulation of Actin Cytoskeleton WP51,0.9975887231072685,0.1630471323875479,0.0003936265449991413,['VIL1'],0.999885714423265,0,0,1
335,Breast cancer pathway WP4262,0.9977882433253975,0.16071546932553096,0.00035585719198023965,['SFRP4'],0.999885714423265,0,0,1
336,EGF/EGFR signaling pathway WP437,0.998891579401619,0.14420076024933456,0.00015992374072931731,['ELK1'],0.999885714423265,0,0,1
337,Ciliary landscape WP4352,0.999885714423265,0.10747027783075846,1.2283004582258637e-05,['NEFM'],0.999885714423265,0,0,1
